Vandetanib - AstraZeneca
At a glance
- Drug Originator AstraZeneca
- Drug Class Antineoplastics; Bromobenzenes; Fluorobenzenes; Piperidines; Quinazolines; Small molecules
- Mechanism of Action Epidermal growth factor receptor antagonists; Proto-oncogene protein c-ret inhibitors; Vascular endothelial growth factor receptor-2 antagonists
- USA Patent Applicants GENZYME CORP
- USA Patents 5
- NDAs 1
- International Patents 40
- Patent Applications 1,040
Disclaimer